US Stock MarketDetailed Quotes
NWBO Northwest Biotherapeutics
- 0.270000
- -0.001500-0.55%
15min DelayTrading Nov 25 12:53 ET
350.31MMarket Cap-4500P/E (TTM)
0.280000High0.267500Low1.95MVolume0.271500Open0.271500Pre Close533.59KTurnover0.17%Turnover RatioLossP/E (Static)1.30BShares0.86000052wk High-4.35P/B320.37MFloat Cap0.24200052wk Low--Dividend TTM1.19BShs Float112.000000Historical High--Div YieldTTM4.60%Amplitude0.140000Historical Low0.273000Avg Price1Lot Size
About Northwest Biotherapeutics Company
Northwest Biotherapeutics, Inc. is a biotechnology company, which engages in the development of personalized immune therapies for cancer. It offers DCVax technology platform, which uses activated dendritic cells to mobilize a patient’s own immune system to attack their cancer. The company was founded by Alton L. Boynton on March 18, 1996 and is headquartered in Bethesda, MD.
Company Profile
SymbolNWBO
Company NameNorthwest Biotherapeutics
Issue Price5.00
Founded1996
MarketPink Market
Employees22
Fiscal Year Ends12-31
Address4800 Montgomery Lane,Suite 800
CityBethesda
ProvinceMaryland
CountryUnited States of America
Zip Code20814
Phone1-240-497-9024
Websitehttp://www.nwbio.com
Company Executives
- Name
- Position
- Salary
- Linda F. Powers
- Chairman of the Board and Chief Executive Officer
- --
- Dr. Marnix L. Bosch
- Chief Technical Officer
- --
- Alton L. Boynton
- Director and Chief Scientific Officer
- --
- Leslie J. Goldman
- Senior Vice President and General Counsel
- --
- Jerry Jasinowski
- Director
- --
- Dr. Navid Malik
- Director
- --
Analysis
Price Target
No Data
Heat List
US
Overall
Symbol
Latest Price
% Chg
No Data